Predicting adverse outcomes after cisplatin administration in head & neack and thoracic cancer (2013)
- Authors:
- USP affiliated authors: BURDMANN, EMMANUEL DE ALMEIDA - FM ; HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- Subjects: INSUFICÊNCIA RENAL (ETIOLOGIA); NEOPLASIAS TORÁCICAS (QUIMIOTERAPIA); NEOPLASIAS DE CABEÇA E PESCOÇO (QUIMIOTERAPIA;COMPLICAÇÕES)
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Cancer
- ISSN: 0959-8049
- Volume/Número/Paginação/Ano: v. 49, supl 2, p. S279, res. 1338, 2013
- Conference titles: European Cancer Congress 2013 Abstract Book
-
ABNT
BITTON, R. C. et al. Predicting adverse outcomes after cisplatin administration in head & neack and thoracic cancer. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529. Acesso em: 27 jan. 2026. , 2013 -
APA
Bitton, R. C., Castria, T. B., Amaral, A. A., Lollo, J. G., Silva, V. T. C. e, Burdmann, E. de A., et al. (2013). Predicting adverse outcomes after cisplatin administration in head & neack and thoracic cancer. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529 -
NLM
Bitton RC, Castria TB, Amaral AA, Lollo JG, Silva VTC e, Burdmann E de A, Hoff PMG, Castro Junior G. Predicting adverse outcomes after cisplatin administration in head & neack and thoracic cancer [Internet]. European Journal of Cancer. 2013 ; 49 S279.[citado 2026 jan. 27 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529 -
Vancouver
Bitton RC, Castria TB, Amaral AA, Lollo JG, Silva VTC e, Burdmann E de A, Hoff PMG, Castro Junior G. Predicting adverse outcomes after cisplatin administration in head & neack and thoracic cancer [Internet]. European Journal of Cancer. 2013 ; 49 S279.[citado 2026 jan. 27 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529 - Predicting adverse outcomes after cisplatin administration in head & neack and thoracic cancer
- Comparison of CKD-EPI, MDRD and Cockcroft-Gault to estimative baseline renal function in patients with head & neck thoracic cancers
- COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: a multicenter study in SAo Paulo, Brazil
- Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
- Acute Kidney Injury: Global Health Alert [Editorial]
- Assessment of kidney function in patients with cancer
- Medical students' and health professionals' knowledge regarding acute kidney injury: a cross-sectional study in the city of Sao Paulo, Brazil
- Censo de Diálise do Brasil de 2009
- Annexin A1 protein attenuates cyclosporine-induced renal hemodynamics changes and macrophage infiltration in rats
- Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
